Latest Biotech News

Sage Therapeutics declined a 30% premium acquisition offer from Biogen CEO Chris Viehbacher after FDA setbacks for its depression drug Zurzuvae and pipeline failures. Following mixed regulatory...

Researchers have developed a novel non-invasive test for nasopharyngeal carcinoma that uses automated analysis of bilateral nasal swab DNA methylation biomarkers. Published in BMC Cancer, this...

A cutting-edge single-cell genomic study reveals detailed developmental and postnatal molecular changes underlying the dup15q syndrome strongly associated with autism spectrum disorder. Published...

A comprehensive retrospective cohort analysis spanning nearly 20 years has identified a U-shaped association between serum lactate dehydrogenase (LDH) levels and all-cause mortality in cancer...

A meta-analysis published in BMC Cancer highlights the efficacy of aerobic exercise interventions in reducing cancer-related fatigue among colorectal cancer patients. The synthesis of existing...

New research reveals that fibroblast growth factor 13 (FGF13) plays a crucial neuroprotective role in preventing age-related cochlear degeneration. The study uncovers mechanisms by which FGF13...

Recent studies illuminate how glucose metabolic pathways critically influence the fate decisions of naïve CD4+ T cells upon activation. This research sheds light on the metabolic rewiring that...

The FDA has eliminated Risk Evaluation and Mitigation Strategies (REMS) for six CAR T-cell therapies targeting multiple myeloma and certain leukemias and lymphomas. This move reflects confidence...

Sage Therapeutics navigated a turbulent period after FDA's partial rejection of its depression drug Zurzuvae and pipeline failures in 2024. Regulatory filings reveal Sage's extensive outreach to...

Researchers revealed fibroblast growth factor 13 (FGF13) plays a critical role in protecting neurons from age-related hearing loss, a discovery with implications for combating auditory decline....

Novel diagnostic technology using DNA methylation biomarkers from bilateral nasal swabs offers a noninvasive, early detection method for nasopharyngeal carcinoma (NPC). Published in BMC Cancer,...

A high-impact study in Nature Communications identified specific brain markers associated with resilience to childhood trauma, revealing modulation by genetic factors. Led by Lu, Rolls, and Liu,...

Recent research has elucidated how glucose metabolism governs the fate decisions of CD4+ T cells, which are central to adaptive immunity. The findings shed light on metabolic reprogramming that...

A pioneering single-cell genomic study published in Nature Communications uncovers detailed molecular and developmental alterations in Dup15q syndrome, a strong genetic cause of autism spectrum...

A fascinating mathematical analysis demonstrates that stacking blocks to create an overhang extending infinitely beyond a table edge is theoretically possible, defying everyday intuition. The...

A recent Nature Communications study highlights a significant 'carbon perception gap' where wealth tiers misjudge their actual carbon footprints. This disparity complicates climate policy...

A comprehensive meta-analysis published in BMC Cancer confirms that aerobic exercise significantly reduces cancer-related fatigue in colorectal cancer patients, improving quality of life and...

The FDA has removed Risk Evaluation and Mitigation Strategies (REMS) for six approved CAR T cell therapies targeting BCMA and CD19, reflecting confidence in established management of key side...

Japanese scientists led by Dr. Ryotaro Hashizume have pioneered the use of CRISPR-Cas9 to remove the extra chromosome 21 responsible for Down syndrome in lab-grown human cells. This...

Researchers have developed a novel, noninvasive diagnostic method for nasopharyngeal carcinoma using DNA methylation biomarkers extracted from bilateral nasal swabs. This approach, detailed in BMC...